Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ischemic Heart Disease

  Free Subscription


03.09.2018

2 Am Heart J
2 Am J Cardiol
1 Angiology
2 BMJ
1 Cardiovasc Res
1 Circ Heart Fail
1 Circ J
3 Eur Heart J
1 Harv Heart Lett
1 Heart
1 Int J Cardiol
8 J Am Coll Cardiol
1 J Mol Cell Cardiol
5 Lancet
1 Mol Cell Biochem
5 N Engl J Med
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am Heart J

  1. XU H, Faxen J, Szummer K, Trevisan M, et al
    Dyskalemias and adverse events associated with discharge potassium in acute myocardial infarction.
    Am Heart J. 2018;205:53-62.
    PubMed     Text format     Abstract available

  2. BURGESS SN, French JK, Nguyen TL, Leung M, et al
    The impact of incomplete revascularization on early and late outcomes in ST-elevation myocardial infarction.
    Am Heart J. 2018;205:31-41.
    PubMed     Text format     Abstract available


    Am J Cardiol

  3. VAVIK V, Pedersen EKR, Svingen GFT, Tell GS, et al
    Usefulness of Higher Levels of Cardiac Troponin T in Patients With Stable Angina Pectoris to Predict Risk of Acute Myocardial Infarction.
    Am J Cardiol. 2018 Jul 4. pii: S0002-9149(18)31319.
    PubMed     Text format     Abstract available

  4. RIOS SA, Bravo CA, Weinreich M, Olmedo W, et al
    Meta-Analysis and Trial Sequential Analysis Comparing Percutaneous Ventricular Assist Devices Versus Intra-Aortic Balloon Pump During High-Risk Percutaneous Coronary Intervention or Cardiogenic Shock.
    Am J Cardiol. 2018 Jul 24. pii: S0002-9149(18)31429.
    PubMed     Text format     Abstract available


    Angiology

  5. DINIZ LR, de Lima SG, de Amorim Garcia JM, de Oliveira Diniz KL, et al
    Neutrophil to Lymphocyte Ratio as a Prognostic Predictor in Older People With Acute Coronary Syndrome.
    Angiology. 2018 Aug 28:3319718796565. doi: 10.1177/0003319718796565.
    PubMed     Text format     Abstract available


    BMJ

  6. CHOWDHURY R, Ramond A, O'Keeffe LM, Shahzad S, et al
    Environmental toxic metal contaminants and risk of cardiovascular disease: systematic review and meta-analysis.
    BMJ. 2018;362:k3310.
    PubMed     Text format     Abstract available

  7. TELLEZ-PLAZA M 1, Guallar E 2, Navas-Acien A 3
    Environmental metals and cardiovascular disease.
    BMJ. 2018;362:k3435.
    PubMed     Text format    


    Cardiovasc Res

  8. LINDSEY ML, Jung M, Yabluchanskiy A, Cannon PL, et al
    Exogenous CXCL4 Infusion Inhibits Macrophage Phagocytosis by Limiting CD36 Signaling to Enhance Post-myocardial Infarction Cardiac Dilation and Mortality.
    Cardiovasc Res. 2018 Aug 29. pii: 5086353. doi: 10.1093.
    PubMed     Text format     Abstract available


    Circ Heart Fail

  9. SCHUTT RC, Bhimiraj A, Estep JD, Guha A, et al
    Deflation Timing Influences Intra-Aortic Balloon Pump-Mediated Carotid Blood Flow Reversal: A Case Report.
    Circ Heart Fail. 2016;9.
    PubMed     Text format    


    Circ J

  10. SUGIURA J, Watanabe M, Toyokawa N, Kamon D, et al
    Progression of a Calcified Nodule Causing Acute Myocardial Infarction in a Patient on Hemodialysis- Serial Optical Coherence Tomography.
    Circ J. 2018 Aug 24. doi: 10.1253/circj.CJ-18-0515.
    PubMed     Text format    


    Eur Heart J

  11. BOEDDINGHAUS J, Nestelberger T, Twerenbold R, Neumann JT, et al
    Impact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarction.
    Eur Heart J. 2018 Aug 29. pii: 5086724. doi: 10.1093.
    PubMed     Text format     Abstract available

  12. THYGESEN K, Alpert JS, Jaffe AS, Chaitman BR, et al
    Fourth universal definition of myocardial infarction (2018).
    Eur Heart J. 2018 Aug 25. pii: 5079081. doi: 10.1093.
    PubMed     Text format    

  13. RYAN N, Escaned J
    Myocardial bridge as a cause of persistent post percutaneous coronary intervention angina identified with exercise intracoronary physiology.
    Eur Heart J. 2016.
    PubMed     Text format    


    Harv Heart Lett


  14. Does loneliness play a role in cardiovascular problems?
    Harv Heart Lett. 2018;28:5.
    PubMed     Text format    


    Heart

  15. SANTO K, Singleton A, Rogers K, Thiagalingam A, et al
    Medication reminder applications to improve adherence in coronary heart disease: a randomised clinical trial.
    Heart. 2018 Aug 27. pii: heartjnl-2018-313479. doi: 10.1136/heartjnl-2018-313479
    PubMed     Text format     Abstract available


    Int J Cardiol

  16. HALL TS, von Lueder TG, Zannad F, Rossignol P, et al
    Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction.
    Int J Cardiol. 2018 Jul 29. pii: S0167-5273(18)30005.
    PubMed     Text format     Abstract available


    J Am Coll Cardiol

  17. MCCARTHY CP, Vaduganathan M, Singh A, Song Z, et al
    Type 2 Myocardial Infarction and the Hospital Readmission Reduction Program.
    J Am Coll Cardiol. 2018;72:1166-1170.
    PubMed     Text format    

  18. FERENCE BA, Graham I, Tokgozoglu L, Catapano AL, et al
    Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series.
    J Am Coll Cardiol. 2018;72:1141-1156.
    PubMed     Text format     Abstract available

  19. STEENSIG K, Olesen KKW, Thim T, Nielsen JC, et al
    Coronary artery disease is independent risk factor for stroke among patients with atrial fibrillation.
    J Am Coll Cardiol. 2018 Aug 23. pii: S0735-1097(18)36961.
    PubMed     Text format    

  20. SILVESTRE OM, Nadruz W Jr, Querejeta Roca G, Claggett B, et al
    Declining Lung Function and Cardiovascular Risk: The ARIC Study.
    J Am Coll Cardiol. 2018;72:1109-1122.
    PubMed     Text format     Abstract available

  21. DUPREZ DA, Jacobs DR Jr
    Lung Function Decline and Increased Cardiovascular Risk: Quo Vadis.
    J Am Coll Cardiol. 2018;72:1123-1125.
    PubMed     Text format    

  22. ADAMSON PD, Anderson JA, Brook RD, Calverley PMA, et al
    Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease.
    J Am Coll Cardiol. 2018;72:1126-1137.
    PubMed     Text format     Abstract available

  23. SHAH NP, Cho L, Ahmed HM
    Familial Chylomicronemia Syndrome: Clinical Characteristics and Long-Term Cardiovascular Outcomes.
    J Am Coll Cardiol. 2018;72:1177-1179.
    PubMed     Text format    

  24. THYGESEN K, Alpert JS, Jaffe AS, Chaitman BR, et al
    Fourth Universal Definition of Myocardial Infarction (2018).
    J Am Coll Cardiol. 2018 Aug 23. pii: S0735-1097(18)36941.
    PubMed     Text format    


    J Mol Cell Cardiol

  25. CAO Y, Xu Y, Auchoybur ML, Chen W, et al
    Regulatory role of IKKa in myocardial ischemia/reperfusion injury by the determination of M1 versus M2 polarization of macrophages.
    J Mol Cell Cardiol. 2018 Aug 25. pii: S0022-2828(18)30843.
    PubMed     Text format     Abstract available


    Lancet

  26. VALGIMIGLI M, Frigoli E, Leonardi S, Vranckx P, et al
    Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
    Lancet. 2018 Aug 24. pii: S0140-6736(18)31714.
    PubMed     Text format     Abstract available

  27. VRANCKX P, Valgimigli M, Juni P, Hamm C, et al
    Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, ope
    Lancet. 2018 Aug 24. pii: S0140-6736(18)31858.
    PubMed     Text format     Abstract available

  28. CAPODANNO D, Angiolillo DJ
    Aspirin for primary prevention of cardiovascular disease.
    Lancet. 2018 Aug 24. pii: S0140-6736(18)31990.
    PubMed     Text format    

  29. GAZIANO JM, Brotons C, Coppolecchia R, Cricelli C, et al
    Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2018 Aug 24. pii: S0140-6736(18)31924.
    PubMed     Text format     Abstract available

  30. ANGIOLILLO DJ
    Vascular access and antithrombotic therapy in patients with acute coronary syndrome.
    Lancet. 2018 Aug 24. pii: S0140-6736(18)31921.
    PubMed     Text format    


    Mol Cell Biochem

  31. NAGOOR MEERAN MF, Laham F, Azimullah S, Tariq S, et al
    alpha-Bisabolol abrogates isoproterenol-induced myocardial infarction by inhibiting mitochondrial dysfunction and intrinsic pathway of apoptosis in rats.
    Mol Cell Biochem. 2018 Aug 29. pii: 10.1007/s11010-018-3434.
    PubMed     Text format     Abstract available


    N Engl J Med


  32. Coronary CT Angiography and 5-Year Risk of Myocardial Infarction.
    N Engl J Med. 2018 Aug 25. doi: 10.1056/NEJMoa1805971.
    PubMed     Text format     Abstract available

  33. ZANNAD F, Anker SD, Byra WM, Cleland JGF, et al
    Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease.
    N Engl J Med. 2018 Aug 27. doi: 10.1056/NEJMoa1808848.
    PubMed     Text format     Abstract available

  34. BOHULA EA, Wiviott SD, McGuire DK, Inzucchi SE, et al
    Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
    N Engl J Med. 2018 Aug 26. doi: 10.1056/NEJMoa1808721.
    PubMed     Text format     Abstract available

  35. WEINER RB, Hucker WJ, Meyersohn NM, Dudzinski DM, et al
    Case 25-2018: A 63-Year-Old Man with Syncope.
    N Engl J Med. 2018;379:670-680.
    PubMed     Text format    

  36. HOFFMANN U, Udelson JE
    Imaging Coronary Anatomy and Reducing Myocardial Infarction.
    N Engl J Med. 2018 Aug 25. doi: 10.1056/NEJMe1809203.
    PubMed     Text format    


    PLoS One

  37. OKABE T, Yakushiji T, Shimazu S, Saito J, et al
    Serum zinc concentration in patients with acute myocardial infarction in percutaneous coronary intervention era.
    PLoS One. 2018;13:e0203074.
    PubMed     Text format     Abstract available

  38. WATANABE H, Ozasa N, Morimoto T, Shiomi H, et al
    Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    PLoS One. 2018;13:e0199347.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  39. HINRICHS S, Scherschel K, Kruger S, Neumann JT, et al
    Precursor proadrenomedullin influences cardiomyocyte survival and local inflammation related to myocardial infarction.
    Proc Natl Acad Sci U S A. 2018 Aug 30. pii: 1721635115.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: